These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Hedlund TE, Moffatt KA, Miller GJ. Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485 [Abstract] [Full Text] [Related]
5. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M. Eur J Immunol; 2008 Aug; 38(8):2210-8. PubMed ID: 18651709 [Abstract] [Full Text] [Related]
7. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes. Stoeckler JD, Stoeckler HA, Kouttab N, Maizel AL. J Immunol; 1996 Dec 01; 157(11):4908-17. PubMed ID: 8943395 [Abstract] [Full Text] [Related]
8. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW. Mol Endocrinol; 2006 Jun 01; 20(6):1447-61. PubMed ID: 16574738 [Abstract] [Full Text] [Related]
12. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ, Peehl DM, Feldman D. Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193 [Abstract] [Full Text] [Related]
13. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism. Tomon M, Tenenhouse HS, Jones G. Endocrinology; 1990 Jun 01; 126(6):2868-75. PubMed ID: 2351099 [Abstract] [Full Text] [Related]
14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
15. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Zhao X, Feldman D. Endocrinology; 1993 Apr 01; 132(4):1808-14. PubMed ID: 8384998 [Abstract] [Full Text] [Related]
16. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. J Endocrinol; 1997 Sep 01; 154 Suppl():S57-73. PubMed ID: 9379138 [Abstract] [Full Text] [Related]